Variational AI will be attending BIO International Convention 2026 in San Diego. We’ll be on-site for partnering meetings to connect with pharma and biotech teams interested in accelerating small-molecule programs with generative AI—especially where speed, novelty, and multi-parameter optimization are key.
Our delegation will include:
Handol Kim,
CEO & Co-Founder
Pete Guzzo,
EVP & Head of Drug Discovery
Valentin Beuchillot,
Director, BD & Marketing